|
시장보고서
상품코드
1762558
세계의 DNA 제조 시장 : 시장 규모, 점유율, 동향, 업계 분석(유형별, 등급별, 용도별, 최종 용도별, 지역별), 예측(2025-2034년)DNA Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Type (Plasmid DNA, Synthetic DNA), By Grade, By Application, End Use, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면, DNA 제조 시장 규모는 2034년까지 218억 2,000만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 향후 시장 성장에 대한 분석을 제공합니다.
합성생물학 또는 유전자 합성으로도 알려진 DNA 제조는 실험실에서 DNA 분자를 인위적으로 만들어내는 과정입니다. 과학자들은 첨단 기술을 활용하여 맞춤형 DNA 염기서열을 설계하고 조립하여 자연에 존재하지 않는 유전 물질을 만들거나 연구 목적으로 기존 염기서열을 복제할 수 있으며, DNA 제조는 생물학, 화학, 공학을 결합하여 정확한 유전자 구조물을 구축하여 의료, 농업, 생명공학 분야의 기술 혁신의 길을 열어줍니다. 의료, 농업, 생명공학 분야의 기술 혁신의 길을 열어주는 것입니다.
DNA 제조의 주요 용도 중 하나는 의학 연구와 의약품 개발입니다. 과학자들은 유전자를 합성하여 질병을 연구하고, 백신을 만들고, 유전자 치료법을 개발합니다. 예를 들어, 합성 DNA는 면역 반응에 대한 유전적 청사진을 제공함으로써 코로나19에 사용되는 것과 같은 mRNA 백신과 치료제를 제조하는 데 도움을 주고 있습니다. 또한, 연구자들은 합성 DNA를 이용한 미생물을 개발하여 인슐린, 항체 및 기타 생명을 구하는 생물학적 제제를 기존 방법보다 더 효율적으로 생산하고 있습니다.
DNA 제조를 통해 과학자들은 희귀 유전성 질환에 대한 유전자 치료, 특정 돌연변이를 표적으로 하는 암 면역 요법 등 맞춤형 유전자 서열을 설계하여 맞춤형 치료법을 개발할 수 있게 되었습니다.
DNA 제조 시장 : 분석 개요
유형별로는 합성 DNA 부문이 치료제, 진단, 합성 생물학에 광범위하게 적용되어 2024년에는 합성 DNA 부문이 주요 시장 점유율을 차지했습니다.
등급별로는 유전자 치료, 세포 치료, DNA 기반 백신과 같은 첨단 치료 용도에 사용되는 임상 등급 DNA에 대한 수요가 증가함에 따라 GMP 등급 부문이 2024년 큰 시장 점유율을 차지했습니다.
용도별로는 세포 및 유전자 치료 분야가 2024년 매출 시장 점유율을 주도했습니다. 이러한 우위는 첨단 치료 플랫폼의 임상 및 상업적 활동의 급속한 확장에 기인합니다.
CRO(임상시험수탁기관) 부문은 향후 몇 년간 견조한 성장세를 보일 것으로 예상되며, CRO는 전문적인 전문성, 확장 가능한 제조, 신속한 납기 등을 통해 의약품 개발에 필수적인 파트너로 자리매김하고 있습니다.
북미 DNA 제조 시장은 2024년 세계 매출 점유율의 47.38%를 차지했습니다. 이러한 우위는 생명공학, 제약, 합성생물학의 발전으로 인한 것입니다.
아시아태평양의 DNA 제조 산업은 바이오 제약 분야의 확대, R&D 투자 증가, 유전체학에 대한 정부 지원으로 인해 향후 몇 년 동안 견조한 성장세를 보일 것으로 예측됩니다.
세계 주요 기업으로는 Catalent, Charles River Laboratories, Danaher, Elegen, Eurofins Genomics, GenScript, Kaneka, Lonza, Probiotech, Thermo Fisher Scientific, Touchlite, VGXI, Wuxi AppTec 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 분석 방법
제4장 세계의 DNA 제조 시장 인사이트
- 시장 현황
- DNA 제조 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTLE 분석
- DNA 제조 시장 동향
- 밸류체인 분석
제5장 세계의 DNA 제조 시장 : 유형별
- 주요 분석 결과
- 서론
- 플라스미드 DNA
- 합성 DNA
제6장 세계의 DNA 제조 시장 : 등급별
- 주요 분석 결과
- 서론
- GMP 등급
- R&D 등급
제7장 세계의 DNA 제조 시장 : 용도별
- 주요 분석 결과
- 서론
- 세포 및 유전자 치료
- 백신
- 올리고뉴클레오티드계 의약품
- 기타
제8장 세계의 DNA 제조 시장 : 최종 용도별
- 주요 분석 결과
- 서론
- 제약 : 바이오테크놀러지 기업
- 학술연구기관
- CRO(의약품 임상시험수탁기관)
제9장 세계의 DNA 제조 시장 : 지역별
- 주요 분석 결과
- 서론
- DNA 제조 시장 분석 : 지역별(2020-2034년)
- 북미
- 북미 : 유형별(2020-2034년)
- 북미 : 등급별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 북미 : 최종 용도별(2020-2034년)
- 미국
- 캐나다
- 유럽
- 유럽 : 유형별(2020-2034년)
- 유럽 : 등급별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 유럽 : 최종 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 유형별(2020-2034년)
- 아시아태평양 : 등급별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 아시아태평양 : 최종 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 유형별(2020-2034년)
- 중동 및 아프리카 : 등급별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 중동 및 아프리카 : 최종 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 유형별, 2020-2034년
- 라틴아메리카 : 등급별, 2020-2034년
- 라틴아메리카 : 용도별(2020-2034년)
- 라틴아메리카 : 최종 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 사업 확대, 기업 인수 분석
- 사업 확대
- 기업 인수
- 제휴/협업/합의/공개
제11장 기업 개요
- Catalent
- Charles River Laboratories
- Danaher
- Elegen
- Eurofins Genomics
- GenScript
- Kaneka Corp.
- Lonza
- ProBio
- Thermo Fisher Scientific
- Touchlight
- VGXI, Inc.
- Wuxi AppTec
The dna manufacturing market size is expected to reach USD 21.82 billion by 2034, according to a new study by Polaris Market Research. The report "DNA Manufacturing Market Size, Share, Trends, & Industry Analysis Report By Type (Plasmid DNA, Synthetic DNA), By Grade, By Application, End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
DNA manufacturing, also known as synthetic biology or gene synthesis, is the process of artificially creating DNA molecules in a laboratory. Scientists design and assemble custom DNA sequences using advanced technologies, enabling them to produce genetic material that does not naturally exist or replicate existing sequences for research purposes. DNA manufacturing combines biology, chemistry, and engineering to build precise genetic constructs, creating the way for innovations in medicine, agriculture, and biotechnology.
One of the primary uses of DNA manufacturing is in medical research and drug development. Scientists synthesize genes to study diseases, create vaccines, and develop gene therapies. For instance, synthetic DNA helps produce mRNA vaccines and therapeutics, such as those used against COVID-19, by providing the genetic blueprint for an immune response. Additionally, researchers develop microbes with synthetic DNA to manufacture insulin, antibodies, and other life-saving biologics more efficiently than traditional methods.
The growing demand for personalized medicine is driving the DNA manufacturing market growth. DNA manufacturing enables scientists to design custom genetic sequences that help create personalized treatments, such as gene therapies for rare genetic disorders or cancer immunotherapies that target specific mutations.
DNA Manufacturing Market Report Highlights
In terms of type, the synthetic DNA segment accounted for a major market share in 2024 due to its widespread applications in therapeutics, diagnostics, and synthetic biology.
Based on grade, the GMP grade segment held a larger market share in 2024 due to rising demand for clinical-grade DNA used in advanced therapeutic applications such as gene therapy, cell therapy, and DNA-based vaccines.
In terms of application, the cell & gene therapy segment dominated the revenue market share in 2024. This dominance is attributed to the rapid expansion of clinical and commercial activity in advanced therapeutic platforms.
Based on end use, the contract research organizations segment is projected to grow at a robust pace in the coming years. CROs offer specialized expertise, scalable manufacturing, and faster turnaround times, making them essential partners for drug development.
The North America DNA manufacturing market accounted for 47.38% of global revenue share in 2024. This dominance is attributed to advancements in biotechnology, pharmaceuticals, and synthetic biology.
The DNA manufacturing industry in Asia Pacific is projected to grow at a robust pace in the coming years, owing to expanding biopharmaceutical sectors, increasing R&D investments, and government support for genomics.
A few global key market players include Catalent; Charles River Laboratories; Danaher; Elegen; Eurofins Genomics; GenScript; Kaneka Corp.; Lonza; ProBio; Thermo Fisher Scientific; Touchlight; VGXI, Inc.; and Wuxi AppTec.
Polaris Market Research has segmented the DNA manufacturing market report on the basis of type, grade, application, end use, and region:
By Type Outlook (Revenue, USD Billion, 2020-2034)
Plasmid DNA
Synthetic DNA
Gene Synthesis
Oligonucleotide Synthesis
By Grade Outlook (Revenue, USD Billion, 2020-2034)
GMP Grade
R&D Grade
By Application Outlook (Revenue, USD Billion, 2020-2034)
Cell & Gene Therapy
Vaccines
Oligonucleotide-Based drugs
Others
By End Use Outlook (Revenue, USD Billion, 2020-2034)
Pharmaceutical and Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations
By Regional Outlook (Revenue, USD Billion, 2020-2034)
North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source
4. Global DNA Manufacturing Market Insights
- 4.1. DNA Manufacturing Market - Market Snapshot
- 4.2. DNA Manufacturing Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing demand for gene therapies
- 4.2.1.2. Rising demand for personalized medicine
- 4.2.2. Restraints and Challenges
- 4.2.2.1. Strict Regulation Norms
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. DNA Manufacturing Market Trends
- 4.6. Value Chain Analysis
5. Global DNA Manufacturing Market, by Type
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Global DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 5.3. Plasmid DNA
- 5.3.1. Global DNA Manufacturing Market, by Plasmid DNA, by Region, 2020-2034 (USD Billion)
- 5.4. Synthetic DNA
- 5.4.1. Global DNA Manufacturing Market, by Synthetic DNA, by Region, 2020-2034 (USD Billion)
- 5.4.2. Gene Synthesis
- 5.4.2.1. Global DNA Manufacturing Market, by Gene Synthesis, by Region, 2020-2034 (USD Billion)
- 5.4.3. Oligonucleotide Synthesis
- 5.4.3.1. Global DNA Manufacturing Market, by Oligonucleotide Synthesis, by Region, 2020-2034 (USD Billion)
6. Global DNA Manufacturing Market, by Grade
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Global DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 6.3. GMP Grade
- 6.3.1. Global DNA Manufacturing Market, by GMP Grade, by Region, 2020-2034 (USD Billion)
- 6.4. R&D Grade
- 6.4.1. Global DNA Manufacturing Market, by R&D Grade, by Region, 2020-2034 (USD Billion)
7. Global DNA Manufacturing Market, by Application
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Global DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 7.3. Cell & Gene Therapy
- 7.3.1. Global DNA Manufacturing Market, by Cell & Gene Therapy, by Region, 2020-2034 (USD Billion)
- 7.4. Vaccines
- 7.4.1. Global DNA Manufacturing Market, by Vaccines, by Region, 2020-2034 (USD Billion)
- 7.5. Oligonucleotide-based drugs
- 7.5.1. Global DNA Manufacturing Market, by Oligonucleotide-based drugs, by Region, 2020-2034 (USD Billion)
- 7.6. Others
- 7.6.1. Global DNA Manufacturing Market, by Others, by Region, 2020-2034 (USD Billion)
8. Global DNA Manufacturing Market, by End Use
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Global DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 8.3. Pharmaceutical and Biotechnology Companies
- 8.3.1. Global DNA Manufacturing Market, by Pharmaceutical and Biotechnology Companies, by Region, 2020-2034 (USD Billion)
- 8.4. Academic & Research Institutes
- 8.4.1. Global DNA Manufacturing Market, by Academic & Research Institutes, by Region, 2020-2034 (USD Billion)
- 8.5. Contract Research Organizations
- 8.5.1. Global DNA Manufacturing Market, by Contract Research Organizations, by Region, 2020-2034 (USD Billion)
9. Global DNA Manufacturing Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. DNA Manufacturing Market Assessment, By Geography, 2020-2034 (USD Billion)
- 9.3. DNA Manufacturing Market - North America
- 9.3.1. North America: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.3.2. North America: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.3.3. North America: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.3.4. North America: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.5. DNA Manufacturing Market - US
- 9.3.5.1. US: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.3.5.2. US: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.3.5.3. US: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.3.5.4. US: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.3.6. DNA Manufacturing Market - Canada
- 9.3.6.1. Canada: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.3.6.2. Canada: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.3.6.3. Canada: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.3.6.4. Canada: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4. DNA Manufacturing Market - Europe
- 9.4.1. Europe: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.2. Europe: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.3. Europe: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.4. Europe: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.5. DNA Manufacturing Market - UK
- 9.4.5.1. UK: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.5.2. UK: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.5.3. UK: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.5.4. UK: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.6. DNA Manufacturing Market - France
- 9.4.6.1. France: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.6.2. France: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.6.3. France: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.6.4. France: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.7. DNA Manufacturing Market - Germany
- 9.4.7.1. Germany: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.7.2. Germany: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.7.3. Germany: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.7.4. Germany: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.8. DNA Manufacturing Market - Italy
- 9.4.8.1. Italy: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.8.2. Italy: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.8.3. Italy: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.8.4. Italy: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.9. DNA Manufacturing Market - Spain
- 9.4.9.1. Spain: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.9.2. Spain: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.9.3. Spain: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.9.4. Spain: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.10. DNA Manufacturing Market - Netherlands
- 9.4.10.1. Netherlands: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.10.2. Netherlands: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.10.3. Netherlands: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.10.4. Netherlands: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.11. DNA Manufacturing Market - Russia
- 9.4.11.1. Russia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.11.2. Russia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.11.3. Russia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.11.4. Russia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.4.12. DNA Manufacturing Market - Rest of Europe
- 9.4.12.1. Rest of Europe: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.4.12.2. Rest of Europe: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.4.12.3. Rest of Europe: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.4.12.4. Rest of Europe: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5. DNA Manufacturing Market - Asia Pacific
- 9.5.1. Asia Pacific: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.5. DNA Manufacturing Market - China
- 9.5.5.1. China: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.5.2. China: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.5.3. China: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.5.4. China: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.6. DNA Manufacturing Market - India
- 9.5.6.1. India: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.6.2. India: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.6.3. India: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.6.4. India: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.7. DNA Manufacturing Market - Malaysia
- 9.5.7.1. Malaysia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.7.2. Malaysia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.7.3. Malaysia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.7.4. Malaysia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.8. DNA Manufacturing Market - Japan
- 9.5.8.1. Japan: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.8.2. Japan: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.8.3. Japan: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.8.4. Japan: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.9. DNA Manufacturing Market - Indonesia
- 9.5.9.1. Indonesia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.9.2. Indonesia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.9.3. Indonesia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.9.4. Indonesia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.10. DNA Manufacturing Market - South Korea
- 9.5.10.1. South Korea: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.10.2. South Korea: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.10.3. South Korea: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.10.4. South Korea: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.11. DNA Manufacturing Market - Australia
- 9.5.11.1. Australia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.11.2. Australia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.11.3. Australia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.11.4. Australia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.5.12. DNA Manufacturing Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.5.12.2. Rest of Asia Pacific: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.5.12.3. Rest of Asia Pacific: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.5.12.4. Rest of Asia Pacific: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.6. DNA Manufacturing Market - Middle East & Africa
- 9.6.1. Middle East & Africa: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.5. DNA Manufacturing Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.6.5.2. Saudi Arabia: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.6.5.3. Saudi Arabia: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.6.5.4. Saudi Arabia: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.6. DNA Manufacturing Market - UAE
- 9.6.6.1. UAE: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.6.6.2. UAE: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.6.6.3. UAE: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.6.6.4. UAE: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.7. DNA Manufacturing Market - Israel
- 9.6.7.1. Israel: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.6.7.2. Israel: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.6.7.3. Israel: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.6.7.4. Israel: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.8. DNA Manufacturing Market - South Africa
- 9.6.8.1. South Africa: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.6.8.2. South Africa: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.6.8.3. South Africa: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.6.8.4. South Africa: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.6.9. DNA Manufacturing Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.6.9.2. Rest of Middle East & Africa: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.6.9.3. Rest of Middle East & Africa: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.6.9.4. Rest of Middle East & Africa: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.7. DNA Manufacturing Market - Latin America
- 9.7.1. Latin America: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.7.2. Latin America: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.7.3. Latin America: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.7.4. Latin America: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.5. DNA Manufacturing Market - Mexico
- 9.7.5.1. Mexico: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.7.5.2. Mexico: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.7.5.3. Mexico: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.7.5.4. Mexico: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.6. DNA Manufacturing Market - Brazil
- 9.7.6.1. Brazil: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.7.6.2. Brazil: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.7.6.3. Brazil: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.7.6.4. Brazil: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.7. DNA Manufacturing Market - Argentina
- 9.7.7.1. Argentina: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.7.7.2. Argentina: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.7.7.3. Argentina: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.7.7.4. Argentina: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
- 9.7.8. DNA Manufacturing Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: DNA Manufacturing Market, by Type, 2020-2034 (USD Billion)
- 9.7.8.2. Rest of Latin America: DNA Manufacturing Market, by Grade, 2020-2034 (USD Billion)
- 9.7.8.3. Rest of Latin America: DNA Manufacturing Market, by Application, 2020-2034 (USD Billion)
- 9.7.8.4. Rest of Latin America: DNA Manufacturing Market, by End Use, 2020-2034 (USD Billion)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Catalent
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Charles River Laboratories
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Danaher
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Elegen
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Eurofins Genomics
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. GenScript
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Kaneka Corp.
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.8. Lonza
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. ProBio
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Thermo Fisher Scientific
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
- 11.11. Touchlight
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development
- 11.12. VGXI, Inc.
- 11.12.1. Company Overview
- 11.12.2. Financial Performance
- 11.12.3. Product Benchmarking
- 11.12.4. Recent Development
- 11.13. Wuxi AppTec
- 11.13.1. Company Overview
- 11.13.2. Financial Performance
- 11.13.3. Product Benchmarking
- 11.13.4. Recent Development
